Literature DB >> 23298137

4-mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK.

G M Campo1, A Avenoso, A D'Ascola, V Prestipino, M Scuruchi, G Nastasi, A Calatroni, S Campo.   

Abstract

4-mer hyaluronan (HA) oligosaccharides stimulate pro-inflammatory effects in different cell types by interacting with both the toll-like receptor-4 (TLR-4) and -2 (TLR-2). This interaction induces the activation of the transforming growth factor activated kinase-1 (TAK-1) that activates the nuclear factor kappaB (NF-kB) either directly and/or through the activation of p38-mitogen-activated protein kinase (p38-MAPK). This in turn induces the transcription of proinflammatory mediators that prime inflammation. Our aim was to investigate the involvement of TAK-1 and p38-MAPK in 4-mer HA oligosaccharide-induced inflammatory response in mouse synovial fibroblasts obtained from normal DBA/J1 mice (NSF) and from mice subjected to collagen-induced arthritis (CIA). Treatment of NSF and rheumatoid arthritis synovial fibroblasts (RASF) with 4-mer HA showed a marked up-regulation of TLR-4, TLR-2, TAK-1 and p38-MAPK mRNA expression and of the related proteins, as well as NF-kB activation. High levels were also detected of TNF-α, IL- 1β, MMP-13 and iNOS. Treatment of NSF and RASF, previously stimulated with 4-mer HA oligosaccharides, with TAK- 1 and/or p38-MAPK specific inhibitors significantly reduced all the parameters, although the inhibitory effect of p38- MAPK was less effective than that of TAK-1. The addition of CD44 antibody to both NSF and RASF showed that CD44 was not involved in 4-mer HA-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298137     DOI: 10.2174/0929867311320090005

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  Beta-arrestin-2 negatively modulates inflammation response in mouse chondrocytes induced by 4-mer hyaluronan oligosaccharide.

Authors:  Giuseppe M Campo; Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Alberto Calatroni; Salvatore Campo
Journal:  Mol Cell Biochem       Date:  2014-10-16       Impact factor: 3.396

2.  In-Vivo Efficacy of Recombinant Human Hyaluronidase (rHuPH20) Injection for Accelerated Healing of Murine Retrocalcaneal Bursitis and Tendinopathy.

Authors:  Sabah N Rezvani; Jinnan Chen; Jun Li; Ron Midura; Valbona Cali; John D Sandy; Anna Plaas; Vincent M Wang
Journal:  J Orthop Res       Date:  2019-09-13       Impact factor: 3.494

Review 3.  Proteoglycans in Toll-like receptor responses and innate immunity.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-08       Impact factor: 5.282

Review 4.  Modulation of hyaluronan signaling as a therapeutic target in human disease.

Authors:  Stavros Garantziotis
Journal:  Pharmacol Ther       Date:  2021-09-26       Impact factor: 12.310

5.  The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells.

Authors:  Jianyan Hu; Tingting Li; Shanshan Du; Yongdong Chen; Shuai Wang; Fen Xiong; Qiang Wu
Journal:  Int J Mol Med       Date:  2015-04-23       Impact factor: 4.101

6.  Clinical Effect of Bushen Huoxue Method Combined with Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis and Its Effect on IL-1, IL-6, VEGF, and PGE-2.

Authors:  Zhengwen Sun; Wenwen Su; Lingyu Wang; Zuowang Cheng; Fengzhen Yang
Journal:  J Healthc Eng       Date:  2022-03-26       Impact factor: 2.682

Review 7.  Extracellular matrix-derived peptides in tissue remodeling and fibrosis.

Authors:  Lisandra E de Castro Brás; Nikolaos G Frangogiannis
Journal:  Matrix Biol       Date:  2020-05-08       Impact factor: 11.583

Review 8.  Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology.

Authors:  Jaime M Cyphert; Carol S Trempus; Stavros Garantziotis
Journal:  Int J Cell Biol       Date:  2015-09-10

Review 9.  Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis.

Authors:  Hua-Feng Zhang; Chen-Guang Wang; Hui Li; Yu-Ting Huang; Zhi-Jun Li
Journal:  Drug Des Devel Ther       Date:  2018-03-05       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.